Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Antonelli A, Ferrari SM, Fallahi P, Frascerra S, Piaggi S, Gelmini S, Lupi C, Minuto M, Berti P, Benvenga S, Basolo F, Orlando C, Miccoli P. Antonelli A, et al. Among authors: minuto m. Endocr Relat Cancer. 2009 Dec;16(4):1299-311. doi: 10.1677/ERC-08-0337. Epub 2009 Sep 15. Endocr Relat Cancer. 2009. PMID: 19755523
Dedifferentiated thyroid cancer: a therapeutic challenge.
Antonelli A, Fallahi P, Ferrari SM, Carpi A, Berti P, Materazzi G, Minuto M, Guastalli M, Miccoli P. Antonelli A, et al. Among authors: minuto m. Biomed Pharmacother. 2008 Oct;62(8):559-63. doi: 10.1016/j.biopha.2008.07.056. Epub 2008 Aug 8. Biomed Pharmacother. 2008. PMID: 18725177 Review.
Thiazolidinediones and antiblastics in primary human anaplastic thyroid cancer cells.
Antonelli A, Ferrari SM, Fallahi P, Berti P, Materazzi G, Minuto M, Giannini R, Marchetti I, Barani L, Basolo F, Ferrannini E, Miccoli P. Antonelli A, et al. Among authors: minuto m. Clin Endocrinol (Oxf). 2009 Jun;70(6):946-53. doi: 10.1111/j.1365-2265.2008.03415.x. Epub 2008 Sep 10. Clin Endocrinol (Oxf). 2009. PMID: 18785992
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer.
Antonelli A, Bocci G, La Motta C, Ferrari SM, Fallahi P, Fioravanti A, Sartini S, Minuto M, Piaggi S, Corti A, Alì G, Berti P, Fontanini G, Danesi R, Da Settimo F, Miccoli P. Antonelli A, et al. Among authors: minuto m. J Clin Endocrinol Metab. 2011 Feb;96(2):E288-96. doi: 10.1210/jc.2010-1905. Epub 2010 Dec 8. J Clin Endocrinol Metab. 2011. PMID: 21147882
New targeted therapies for anaplastic thyroid cancer.
Antonelli A, Fallahi P, Ulisse S, Ferrari SM, Minuto M, Saraceno G, Santini F, Mazzi V, D'Armiento M, Miccoli P. Antonelli A, et al. Among authors: minuto m. Anticancer Agents Med Chem. 2012 Jan;12(1):87-93. doi: 10.2174/187152012798764732. Anticancer Agents Med Chem. 2012. PMID: 22043992
Peroxisome proliferator-activated receptor-α agonists modulate CXCL9 and CXCL11 chemokines in Graves' ophthalmopathy fibroblasts and preadipocytes.
Antonelli A, Ferrari SM, Frascerra S, Ruffilli I, Gelmini S, Minuto M, Pupilli C, Miccoli P, Sellari-Franceschini S, Ferrannini E, Fallahi P. Antonelli A, et al. Among authors: minuto m. Mol Cell Endocrinol. 2012 Feb 26;349(2):255-61. doi: 10.1016/j.mce.2011.11.001. Epub 2011 Nov 12. Mol Cell Endocrinol. 2012. PMID: 22101320
83 results